Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 14, 2015; 21(42): 12022-12041
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12022
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12022
Type of nanocarrier | NPs composition | Targeted for receptor | Active moiety | Specific Remarks | Ref. |
Synthetic or natural polymeric NPs | Polyethylenglycol (PEG), dithiodipropionate, hyaluronic acid | Asialogycoprotein receptor (ASGPR) , no receptor (EPR effect) | Doxorubicin (DOX) | The NPs were sensitive to acidic environment of endosomes and high intracellular Glutathion concentrations | [62] |
Synthetic or natural polymeric NPs | poly(caprolactone), PEG | no receptor (EPR effect) | Docetaxel | The NPs had a long circulating characteristic and longer retention time in tumor cells | [63] |
Synthetic or natural polymeric NPs | Galactose (GA), chitosan, | ASGPR | 5-FU | - | [66,74,75] |
Synthetic or natural polymeric NPs | O-carboxymethyl chitosan, GA | ASGPR | Paclitaxel (PTX) | - | [68] |
Synthetic or natural polymeric NPs | Hyaluronic acid (HA), GA | ASGPR | PTX | The dual targeting allows for the NPs to get internalized by tumor cells more specifically | [69] |
Synthetic or natural polymeric NPs | Hematoporphyrin, Bovine serum albumin (BSA) | LDL | DOX | The photosensitizing properties of hematoporphyrin allowed for an accurate monitoring of NP uptake by imaging | [88] |
Synthetic or natural polymeric NPs | Heat-liable enterotoxin subunite B (LTB), BSA | Ganglioside GM1 receptor | 5-FU | - | [92] |
Synthetic or natural polymeric NPs | Galactosylated chitosan, polycaprolactone | ASGPR | Curcumin | - | [72] |
Synthetic or natural polymeric NPs | Galactosylated chitosan, mPEG-SH | ASGPR | Norcantharidin (NCTD) | The drug was actually loaded using ionic cross linkage between NCTD and chitosan | [76] |
Synthetic or natural polymeric NPs | SM5-1, PLA | Membrane antigens | 5-FU | - | [96] |
Synthetic or natural polymeric NPs | Apotransferin, BSA | transferrin receptor | DOX | - | [138] |
Synthetic or natural polymeric NPsSynthetic or natural polymeric NPs | Apotransferrin, LactoferrinChitosan, retinoic acid (RA), Albumin | Transferrin receptorRA receptor | DOXDOX | -- | [139][105] |
Mixed NPs | GA, DOX, Alginate | ASGPR | DOX | - | [70] |
Mesoporous high surface area silica core fused to a liposome (protocell) | Silica, PEG, Zwitterionic lipids, phosphatidylethanolamine | SP94 receptor, no receptor (EPR effect) | DOX | The fusogenic peptide used allows for more efficient internalization. The nanoporous silica core also gives the NPs, a significantly higher surface area | [64] |
Nano micelle | PEG, polycaprolactone, SPION, folate | Folate receptor | Sorafenib | The SPION loaded NPs could be efficiently monitored using MR imaging | [128] |
Nano micelle | RGD, PEG, stearic acid, chitosan | Integrins | DOX | - | [112] |
Nano liposome | egg phosphatidylcholine, cholesterol, monomethoxy PEG-distearoyl phosphatidylethanolamine, and Lactose - dioleyl phosphatidylethanolamine (DOPE) | ASGPR | DOX | - | [73] |
Nano liposome | Anti CD44 antibody, cholesterol, DOPE, DSPC, DSPE-(PEO)4-cRGDfK, DSPE-mPEG | CD44 | DOX | - | [97] |
Lipid nanocarriers | Lactobionic acid, Stearyl amine, lecithin, glyceryl monostearate, oleic acid | AGPR | 5-FU | - | [71] |
Magnetic NPs | FeCl2, FeCl3, CMC, EpCAM aptamer | Epithelial cell adhesion molecule | DOX | These magnetic nanoparticles were suggested as a candidate for MR imagine of HCC | [113] |
Magnetic NPs | Fe3O4/Fe, silica | no receptor (EPR effect) | ABT-888, Temozolamide | The co-delivery of the two drugs both inhibits transcription of survival genes and has cytotoxic effect | [65] |
BSA NPs | Glycyrrhizic acid (GA), BSA, 10-hydroxycamptothecin (HCPT) | ASGPR | FITC | - | [67] |
Gold NP | Gold, cetuximab | EGFR | gemcitabine | When coupled with RF-hyperthermia, these NPs were significantly effective at tumor growth inhibition | [94] |
Nanosuspension | DSPE, PEG, FA, soy lecithin | Folate receptor | Docetaxel | - | [136] |
Dendrimer | poly(methacryloyl sulfadimethoxine) (PSD), PEG, Lactose | ASGPR | DOX | - | [77] |
Virus-like NP | MS2 capsid, Ricin toxin A chain, SP94, H5WYG fusogenic peptide, PEG | SP94 receptor | DOX, cisplatin, 5-FU | - | [142] |
Core-shell NP | Poly(vinyl alcohol), albumin | Transferrin receptor | DOX, sorafenib | The synergistic effect of DOX and sorafenib here increased tumor inhibition more significantly | [141] |
Miscellaneous | PLGA, PVA, chitosan, Asialofetuin | ASGPR | EPI | Co-delivery of EPI with tocotrienols as anti-oxidative agents, resulted in significantly lower cardiotoxicity and higher apoptosis level | [85] |
Miscellaneous | Benzyl malolactonate, PEG, Fluorescein amine, Biotin, cyclic Biotin-RGD peptide, streptavidin | Biotin Receptor, integrins | DOX | The use of streptavidin for grafting a peptide suggests that a number of peptides could be grafted in NPs without needing any additional chemistry | [115] |
Type of nanocarrier | Active moiety | Targeted receptor | Suggested Mechanism | Ref. |
Lipid nanoparticle | TetR siRNA | - | - | [31] |
Novel nonocarrier consisting of a silica core fused to liposomes (called protocell) | Model siRNA | SP94 protein and EPR | - | [64] |
Galactose mediated trimethylchitosan cysteine NPs | VEGF-siRNA and Survivin shRNA-expression pDNA (iSUR-pDNA) | ASGPR | Silencing of tumor growth genes | [86] |
A phospholipid-cholesterol nanocomplex | Pokemon siRNA | LDL receptor | Cell growth inhibition | [89] |
A SPION called SilenceMag | Human VEGF siRNA | EGFR | Tumor growth inhibition | [95] |
PEGylated Polyethyleneamine SPION | Survivin siRNA | Integrin | Induction of apoptosis | [114] |
Virus-like nanoparticle of bacteriophage MS2 | Anti-cyclin siRNA | Folic acid receptor, SP94, transferrin receptor | Induction of apoptosis | [142] |
Lipid nanoparticle | Integrin b1 siRNA | integrin | Inhibition of proliferation and tumor cell death | [116] |
- Citation: Varshosaz J, Farzan M. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12022-12041
- URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12022.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12022